|
1
|
Mohamed AN, Bentley G, Bonnett ML, Zonder
J and Al-Katib A: Chromosome aberrations in a series of 120
multiple myeloma cases with abnormal karyotypes. Am J Hematol.
82:1080–1087. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dupéré-Richer D and Licht JD: Epigenetic
regulatory mutations and epigenetic therapy for multiple myeloma.
Curr Opin Hematol. 24:336–344. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Manier S, Salem KZ, Park J, Landau DA,
Getz G and Ghobrial IM: Genomic complexity of multiple myeloma and
its clinical implications. Nat Rev Clin Oncol. 14:100–113. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mallo GV, Fiedler F, Calvo EL, Ortiz EM,
Vasseur S, Keim V, Morisset J and Lovanna JL: Cloning and
expression of the rat p8 cDNA, a new gene activated in pancreas
during the acute phase of pancreatitis, pancreatic development, and
regeneration, and which promotes cellular growth. J Biol Chem.
272:32360–32369. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cano CE, Hamidi T, Sandi MJ and Iovanna
JL: Nupr1: The Swiss-knife of cancer. J Cell Physiol.
226:1439–1443. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sandi MJ, Hamidi T, Malicet C, Cano C,
Loncle C, Pierres A, Dagorn JC and Lovanna JL: p8 expression
controls pancreatic cancer cell migration, invasion, adhesion, and
tumorigenesis. J Cell Physiol. 226:3442–3451. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Emma MR, Iovanna JL, Bachvarov D, Puleio
R, Loria GR, Auqello G, Candido S, Libra M, Gulino A, Cancila V, et
al: NUPR1, a new target in liver cancer: Implication in controlling
cell growth, migration, invasion and sorafenib resistance. Cell
Death Dis. 7:e22692016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Veerla S, Panagopoulos I, Jin Y, Lindgren
D and Höglund M: Promoter analysis of epigenetically controlled
genes in bladder cancer. Genes Chromosomes Cancer. 47:368–378.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ito Y, Yoshida H, Motoo Y, Lovanna JL,
Nakamura Y, Kakudo K, Uruno T, Takamura Y, Miya A, Noquchi S, et
al: Expression of p8 protein in breast carcinoma; an inverse
relationship with apoptosis. Anticancer Res. 25:833–837.
2005.PubMed/NCBI
|
|
10
|
Di Martino MT, Guzzi PH, Caracciolo D,
Aqnelli L, Neri A, Walker BA, Morqan GJ, Cannataro M, Tassone P and
Taqliaferri P: Integrated analysis of microRNAs, transcription
factors and target genes expression discloses a specific molecular
architecture of hyperdiploid multiple myeloma. Oncotarget.
6:19132–19147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Palumbo A, Avet-Loiseau H, Oliva S,
Lokhorst HM, Goldschmidt H, Rosinol L, Richardson P, Caltagirone S,
Lahuerta JJ, Facon T, et al: Revised international staging system
for multiple myeloma: A report from international myeloma working
group. J Clin Oncol. 33:2863–2869. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scherr M and Eder M: Gene transfer into
hematopoietic stem cells using lentiviral vectors. Curr Gene Ther.
2:45–55. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo X, Wang W, Hu J, Feng K, Pan Y, Zhang
L and Feng L: Lentivirus-mediated RNAi knockdown of NUPR1 inhibits
human nonsmall cell lung cancer growth in vitro and in vivo. Anat
Rec. 295:2114–2121. 2012. View
Article : Google Scholar
|
|
15
|
Pedrola N, Devis L, Llauradó M, Campoy I,
Martinez-Garcia E, Garcia M, Muinelo-Romay L, Alonso-Alconada L,
Abal M, Alameda F, et al: Nidogen 1 and nuclear protein 1: Novel
targets of ETV5 transcription factor involved in endometrial cancer
invasion. Clin Exp Metastasis. 32:467–478. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang WG, Davies G, Martin TA, Kynaston H,
Mason MD and Fodstad O: Com-1/p8 acts as a putative tumour
suppressor in prostate cancer. Int J Mol Med. 18:981–986.
2006.PubMed/NCBI
|
|
17
|
Kong DK, Georgescu SP, Cano C, Aronovitz
MJ, Lovanna JL, Patten RD, Kyriakis JM and Goruppi S: Deficiency of
the transcriptional regulator p8 results in increased autophagy and
apoptosis, and causes impaired heart function. Mol Biol Cell.
21:1335–1349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goruppi S and Iovanna JL: Stress-inducible
protein p8 is involved in several physiological and pathological
processes. J Biol Chem. 285:1577–1581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Ren S, Liu Y, Lian Z, Dong B, Yao Y
and Xu Y: Knockdown of NUPR1 inhibits the proliferation of
glioblastoma cells via ERK1/2, p38 MAPK and caspase-3. J
Neurooncol. 132:15–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lorente M, Carracedo A, Torres S, Natali
F, Eqia A, Hernández-Tiedra S, Salazar M, Blázquez C, Guzman M and
Velasco G: Amphiregulin is a factor for resistance of glioma cells
to cannabinoid-induced apoptosis. Glia. 57:1374–1385. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Su SB, Motoo Y, Iovanna JL, Berthézène P,
Xie MJ, Mouri H, Ohtsubo K, Matsubara F and Sawabu N:
Overexpression of p8 is inversely correlated with apoptosis in
pancreatic cancer. Clin Cancer Res. 7:1320–1324. 2001.PubMed/NCBI
|
|
22
|
Malicet C, Giroux V, Vasseur S, Dagorn JC,
Neira JL and Iovanna JL: Regulation of apoptosis by the
p8/prothymosin alpha complex. Proc Natl Acad Sci USA.
103:2671–2676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fulda S and Debatin KM: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reed JC and Pellecchia M: Apoptosis-based
therapies for hematologic malignancies. Blood. 106:408–418. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mahler M, Miyachi K, Peebles C and
Fritzler MJ: The clinical significance of autoantibodies to the
proliferating cell nuclear antigen (PCNA). Autoimmun Rev.
11:771–775. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gregorian C, Nakashima J, Dry SM,
Nghiemphu PL, Smith KB, Ao Y, Dang J, Lawson G, Mellinghoff IK,
Mischel PS, et al: PTEN dosage is essential for neurofibroma
development and malignant transformation. Proc Natl Acad Sci USA.
106:19479–19484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song L, Liu S, Zhang L, Yao H, Gao F, Xu D
and Li Q: MiR-21 modulates radiosensitivity of cervical cancer
through inhibiting autophagy via the PTEN/Akt/HIF-1alpha feedback
loop and the Akt-mTOR signaling pathway. Tumour Biol.
37:12161–12168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ,
Zhang XH, Zhong SL, Zhao JH and Tang JH: miR-222 induces Adriamycin
resistance in breast cancer through PTEN/Akt/p27kip1
pathway. Tumour Biol. 37:15315–15324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu DY, Li XN, Qi Y, Liu DL, Yang Y, Zhao
J, Zhang CY, Wu K and Zhao S: MiR-454 promotes the progression of
human non-small cell lung cancer and directly targets PTEN. Biomed
Pharmacother. 81:79–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiaozhou L, Xing Z, Haidong X, Zhiwei H,
Xin S and Sujia W: SLC34A2 regulates the proliferation, migration,
and invasion of human osteosarcoma cells through PTEN/PI3K/AKT
signaling. DNA Cell Biol. 36:775–780. 2017.PubMed/NCBI
|
|
33
|
Chappell WH, Steelman LS, Long JM, Kempf
RC, Abrams SL, Franklin RA, Bäsecke J, Stivala F, Donia M, Fagone
P, et al: Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors:
Rationale and importance to inhibiting these pathways in human
health. Oncotarget. 2:135–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang F, Shi L, Liang T, Ji L, Zhang G,
Shen Y, Zhu F and Xu L: Anti-tumor effect of evodiamine by inducing
Akt-mediated apoptosis in hepatocellular carcinoma. Biochem Biophys
Res Commun. 485:54–61. 2017. View Article : Google Scholar : PubMed/NCBI
|
